Passage Bio

Passage Bio is a gene therapy company currently focused on the development of five drugs for treating monogenic central nervous system diseases. Headquartered in Philadelphia, Pennsylvania, the company has established cooperative agreements with the University of Pennsylvania and the Orphan Disease Center (ODC).